BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16584165)

  • 41. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
    Soler LI; Boix A; Lauroba J; Colom H; Domenech J
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil.
    Al-Saidan SM; Krishnaiah YS; Chandrasekhar DV; Lalla JK; Rama B; Jayaram B; Bhaskar P
    Skin Pharmacol Physiol; 2004; 17(6):310-20. PubMed ID: 15528962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of transdermal clonidine in chronic hemodialysis patients.
    Rosansky SJ; Johnson KL; McConnell J
    Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
    Spieker C; Vetter W; Zidek W; Vetter H
    Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
    Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved blood pressure control by monitoring compliance with antihypertensive therapy.
    Waeber B; Vetter W; Darioli R; Keller U; Brunner HR
    Int J Clin Pract; 1999; 53(1):37-8. PubMed ID: 10344064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What is the future of heated transdermal delivery systems?
    Otto DP; de Villiers MM
    Ther Deliv; 2014; 5(9):961-4. PubMed ID: 25375338
    [No Abstract]   [Full Text] [Related]  

  • 48. Editorial note.
    Alonso MJ
    Drug Deliv Transl Res; 2024 Jul; 14(7):1735-1736. PubMed ID: 38713399
    [No Abstract]   [Full Text] [Related]  

  • 49. Transdermal delivery of calcium channel blockers for hypertension.
    Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Aqil M; Kohli K
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1137-53. PubMed ID: 23527660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
    Goswami T; Audett J
    Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo characterization of monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: a technical note.
    Aqil M; Ali A; Sultana Y; Dubey K; Najmi AK; Pillai KK
    AAPS PharmSciTech; 2006 Jan; 7(1):E6. PubMed ID: 16584165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil.
    Aqil M; Ali A; Sultana Y; Najmi AK
    Pharmazie; 2004 Aug; 59(8):631-5. PubMed ID: 15378854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation.
    Aqil M; Ali A
    Eur J Pharm Biopharm; 2002 Sep; 54(2):161-4. PubMed ID: 12191687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo characterization of monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: A technical note.
    Aqil M; Ali A; Sultana Y; Dubey K; Najmi AK; Pillai KK
    AAPS PharmSciTech; 2006 Mar; 7(1):E38-E42. PubMed ID: 28290021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiation preparation of L-arginine/acrylic acid hydrogel matrix patch for transdermal delivery of propranolol HCl in hypertensive rats.
    Radwan RR; Mohamed HA; Ali HE; Mahmoud GA
    Drug Deliv Transl Res; 2018 Jun; 8(3):525-535. PubMed ID: 29313295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacodynamics of a losartan transdermal system for the treatment of hypertension.
    Shams MS; Alam MI; Ali A; Sultana Y; Aqil M
    Drug Dev Ind Pharm; 2010 Apr; 36(4):385-92. PubMed ID: 20205600
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.